Should I buy or sell Thorne HealthTech stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" THRN shares. View THRN analyst ratings or view top-rated stocks .

What is Thorne HealthTech's stock price target for 2024?

2 Wall Street research analysts have issued 12-month target prices for Thorne HealthTech's stock. Their THRN share price targets range from $7.00 to $10.20. On average, they predict the company's stock price to reach $8.60 in the next year. This suggests that the stock has a possible downside of 15.6%. View analysts price targets for THRN or view top-rated stocks among Wall Street analysts .

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) released its quarterly earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.03. The business earned $48.01 million during the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?

Thorne HealthTech (THRN) raised $98 million in an IPO on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

NASDAQ:THRN

Thorne HealthTech (THRN) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free THRN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.19
▼
$10.19
50-Day Range: $10.13
▼
$10.20
52-Week Range: $3.41
▼
$10.20

Volume: N/A
Average Volume: 110,986 shs
Market Capitalization: $549.44 million

P/E Ratio: 26.82
Dividend Yield: N/A
Price Target: $8.60

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Social Media

Get Thorne HealthTech alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Thorne HealthTech Stock (NASDAQ:THRN)

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

THRN Stock News Headlines

February 22, 2024 | health.usnews.com

Dr. Gary A. Thorne

February 3, 2024 | health.usnews.com

Lisa D. Thorne

April 16, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

December 22, 2023 | morningstar.com

THORNE HEALTHTECH ANNOUNCES INNOVATION ARM UNDER THORNE VENTURES

December 8, 2023 | bbc.com

Bella Thorne, OnlyFans and the battle over monetising content

November 17, 2023 | health.usnews.com

Dr. Doris K. Thorne

October 16, 2023 | finance.yahoo.com

L Catterton Completes Acquisition of Thorne HealthTech, Inc.

October 13, 2023 | finance.yahoo.com

L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer

April 16, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

October 11, 2023 | msn.com

Evercore ISI Group Downgrades Thorne Healthtech (THRN)

September 20, 2023 | markets.businessinsider.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Thorne HealthTech, Inc. (THRN)

September 19, 2023 | finance.yahoo.com

Should You Be Adding Thorne HealthTech (NASDAQ:THRN) To Your Watchlist Today?

September 7, 2023 | bloomberg.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN

August 30, 2023 | msn.com

TD Cowen Downgrades Thorne Healthtech (THRN)

August 30, 2023 | benzinga.com

THORNE HEALTHTECH INVESTOR ALERT by the Former...

August 29, 2023 | jp.reuters.com

Thorne HealthTech Inc

August 28, 2023 | benzinga.com

Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton

August 28, 2023 | msn.com

Thorne HealthTech Goes Private In $680M Cash Deal With L Catterton; Stock Soars

August 28, 2023 | finance.yahoo.com

Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash

August 23, 2023 | msn.com

Thorne HealthTech trades higher, extending month-long gains

August 23, 2023 | finance.yahoo.com

Investing in Thorne HealthTech (NASDAQ:THRN) a year ago would have delivered you a 46% gain

August 22, 2023 | msn.com

TWOU, OTLY and LWAY among mid-day movers

August 12, 2023 | seekingalpha.com

Thorne HealthTech, Inc. 2023 Q2 - Results - Earnings Call Presentation

August 11, 2023 | msn.com

Portfolio Change: Two Stocks To Sell, August 11

August 9, 2023 | seekingalpha.com

Thorne HealthTech Non-GAAP EPS of $0.15, revenue of $72.7M

August 9, 2023 | msn.com

Update: THRN and FREE, August 9

August 9, 2023 | finanznachrichten.de

Thorne HealthTech, Inc.: Thorne HealthTech Reports Second Quarter 2023 Results

See More Headlines

Receive THRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thorne HealthTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Consumer Defensive
Industry: Packaged Foods
Sub-Industry: N/A
Current Symbol: NASDAQ:THRN
CUSIP: N/A
CIK: 1844280
Web: www.thorne.com
Phone: 929-251-6321
Fax: N/A
Employees: 544
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $8.60
High Stock Price Target: $10.20
Low Stock Price Target: $7.00
Potential Upside/Downside: -15.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.38
Trailing P/E Ratio: 26.82
Forward P/E Ratio: 35.14
P/E Growth: N/A
Net Income: $15.67 million
Net Margins: 7.84%
Pretax Margin: 5.59%
Return on Equity: 9.03%
Return on Assets: 5.57%

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 2.41
Quick Ratio: 1.13

Sales & Book Value

Annual Sales: $228.73 million
Price / Sales: 2.40
Cash Flow: $0.26 per share
Price / Cash Flow: 39.41
Book Value: $2.78 per share
Price / Book: 3.67

Miscellaneous

Outstanding Shares: 53,920,000
Free Float: 13,480,000
Market Cap: $549.44 million
Optionable: Not Optionable
Beta: 0.82

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Paul F. Jacobson (Age 68)
Co-Founder, CEO & Chairman
Comp: $965k
Mr. William C. McCamy (Age 53)
Pres
Comp: $478.95k
Ms. Saloni S. Varma (Age 44)
CFO & Director
Comp: $75k
Mr. Thomas P. McKenna (Age 63)
COO & Director
Comp: $805.95k
Mr. Scott R. Hurth (Age 43)
Chief Technology Officer
Dr. Nathan D. Price Ph.D. (Age 47)
Chief Scientific Officer & CEO of Onegevity
Mr. Thomas Wilson
VP & Head of Investor Relations
Mr. Kim R. Pearson (Age 71)
Gen. Counsel
Ms. Michelle L. Crow (Age 33)
Chief Marketing Officer
Mr. Rob Monteleone
Sr. VP of Professional Sales

Key Competitors

View All Competitors

THRN Stock Analysis - Frequently Asked Questions

Should I buy or sell Thorne HealthTech stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thorne HealthTech in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" THRN shares.
View THRN analyst ratings or view top-rated stocks.
What is Thorne HealthTech's stock price target for 2024?: 2 Wall Street research analysts have issued 12-month target prices for Thorne HealthTech's stock. Their THRN share price targets range from $7.00 to $10.20. On average, they predict the company's stock price to reach $8.60 in the next year. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for THRN or view top-rated stocks among Wall Street analysts.
How were Thorne HealthTech's earnings last quarter?: Thorne HealthTech, Inc. (NASDAQ:THRN) released its quarterly earnings results on Wednesday, November, 10th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.03. The business earned $48.01 million during the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.
When did Thorne HealthTech IPO?: Thorne HealthTech (THRN) raised $98 million in an IPO on Thursday, September 23rd 2021. The company issued 7,000,000 shares at a price of $13.00-$15.00 per share.

This page (NASDAQ:THRN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Thorne HealthTech (THRN) Stock Price, News & Analysis

About Thorne HealthTech Stock (NASDAQ:THRN)

THRN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

THRN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info